Potassium iodide
CAS No. 7681-11-0
Potassium iodide( —— )
Catalog No. M15904 CAS No. 7681-11-0
Potassium iodide is used to treat overactive thyroid and to protect the thyroid gland from the effects of radiation from inhaled or swallowed radioactive iodine.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 62 | In Stock |
|
| 25MG | 218 | In Stock |
|
| 50MG | 301 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NamePotassium iodide
-
NoteResearch use only, not for human use.
-
Brief DescriptionPotassium iodide is used to treat overactive thyroid and to protect the thyroid gland from the effects of radiation from inhaled or swallowed radioactive iodine.
-
DescriptionPotassium iodide is used to treat overactive thyroid and to protect the thyroid gland from the effects of radiation from inhaled or swallowed radioactive iodine. It may be used before and after administration of medicine containing radioactive iodine or after accidental exposure to radioactive iodine.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayProteasome/Ubiquitin
-
TargetTyrosinase
-
RecptorTyrosinase
-
Research AreaOther Indications
-
Indication——
Chemical Information
-
CAS Number7681-11-0
-
Formula Weight166.01
-
Molecular Formula——
-
Purity>98% (HPLC)
-
SolubilityWater: 33 mg/mL (198.79 mM); DMSO: 33 mg/mL (198.79 mM)
-
SMILES[K+].[I-]
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Pisarev MA, Aiello LO. Acta Endocrinol (Copenh). 1976 Jun;82(2):298-305.
molnova catalog
related products
-
Glycolic acid
Glycolic acid is an inhibitor of tyrosinase suppressing melanin formationand used in skincare products
-
ZAP-180013
ZAP-180013 is an inhibitor of zeta-chain-associated protein kinase 70 (ZAP70,IC50 : 1.8 μM).
-
5-Feruloylquinic aci...
5-O-Feruloylquinic acid is a potent Sirt1 agonist, it is a potential lead compound that can be further tested in drug development process for diseases associated with aging.
Cart
sales@molnova.com